Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
R RESPIRATORY SYSTEM
R06 ANTIHISTAMINES FOR SYSTEMIC USE
R06A ANTIHISTAMINES FOR SYSTEMIC USE
R06AX Other antihistamines for systemic use
R06AX28 Rupatadine
D08497 Rupatadine fumarate (JAN) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
4 Agents affecting cellular function
44 Allergic agents
449 Miscellaneous
4490 Miscellaneous
D08497 Rupatadine fumarate (JAN)
Drug groups [BR:br08330]
Anti-allergic agent
DG01557 Histamine receptor antagonist
DG01482 Histamine receptor H1 antagonist
DG01118 Rupatadine
D08497 Rupatadine fumarate
Dermatological agent
DG03243 Atopic dermatitis agent
D08497 Rupatadine fumarate
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG01118 Rupatadine
D08497 Rupatadine fumarate
Drug classes [BR:br08332]
Anti-allergic agent
DG01482 Histamine receptor H1 antagonist
D08497 Rupatadine fumarate
Dermatological agent
DG03243 Atopic dermatitis agent
D08497 Rupatadine fumarate
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Histamine
HRH1
D08497 Rupatadine fumarate (JAN) <JP>
Platelet activating factor
PTAFR
D08497 Rupatadine fumarate (JAN) <JP>
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D08497
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D08497
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D08497
Drug groups [BR:br08330]
Anti-allergic agent
DG01557 Histamine receptor antagonist
DG01482 Histamine receptor H1 antagonist
DG01118 Rupatadine
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG01118 Rupatadine